Biogen Inc. - Company & Market Research Reports

Home /
Companies /
Biogen Inc.

Founded in 1978 Biogen Inc is a global biotechnology company with its headquarters in Cambridge, Massachusetts. In 2003 Biogen merged with Idec Pharmaceuticals to create Biogen Idec and acquired Syntonix Pharmaceuticals in 2007. In 2015 the company returned to its original name Biogen Inc and acquired Convergence Pharmaceuticals. Biogen focuses on drug discovery for a range of conditions including neuropathic pain, hemophilia, organ failure, neuromuscular disorders and oncology. Their product portfolio includes Rituxan, Avonex, Tecfidera and Eloctate.

REFINE BY

KEYWORD

CATEGORIES

Central Nervous System Drugs 160
Immune Disorders Drugs 77
Genomics 76
Biopharmaceuticals 76
Biotechnology 50
Drug Discovery 47
Pharmaceuticals 45
Oncology Drugs 44
Musculoskeletal Disorders Drugs 43
Hematological Drugs 37
Biosimilars and Biosuperiors 33
Alzheimer's Disease Drugs 28
Cardiovascular Drugs 26
Clinical Trials 25
Infusions and Injectables 25
Allergy and Immunology 22
Optical Disorders Drugs 21
Mental Disorders Drugs 19
Needles and Syringes 17
Neurology 16
Respiratory Drugs 16
Psoriasis Drugs 15
E-Healthcare 14
Infectious Diseases Drugs 14
Optical 12
Pharmaceutical Manufacturing 12
Immunosuppressive Drugs 12
Healthcare Services 11
Hematology 11
Gastrointestinal Drugs 11
Endocrine and Metabolic Disorders Drugs 11
Therapeutic Area 10
Diagnostics 10
Drug Delivery 10
Drugs by Therapeutic Area 9
Leukemia Drugs 9
Lymphoma Drugs 9
Analgesics 9
Pulmonary Medicine 7
Liver and Kidney Disorders Drugs 7
Medical Devices 6
Oncology 6
Proteomics 5
Enzymes 5
Hospital Management 5
Cardiology 5
Schizophrenia Drugs 5
Company Reports 4
Mental Health 4
Neurology Devices 4
Laboratory Equipment 4
Dermatological Drugs 4
Pharmaceutical Intermediates 3
Generic Drugs 3
Stem Cells 3
Dermatology 3
Vitamins and Dietary Supplements 3
Gastroenterology 3
Urology and Nephrology 2
Pharmacoeconomics 2
Lung Cancer Drugs 2
Prostate Cancer Drugs 2
In Vitro Diagnostics 2
Managed Care 2
Diabetes Devices 2
Biomaterials 2
Biomarkers 2
Vaccines 2
Skin Cancer Drugs 2
Pediatrics 2
Anxiety Drugs 2
Addiction Disorders Drugs 1
Diabetes Drugs 1
Women's Health 1
Fertility Services 1
Breast Cancer Drugs 1
Colon Cancer Drugs 1
Cervical Cancer Drugs 1
Brain Cancer Drugs 1
Medical Imaging 1
Infectious Disease Testing 1
Transdermal and Transmucosal Drug Delivery 1
Contrast Media 1
Kidney Cancer Drugs 1
Nanomedicine 1
Antibiotics 1
Clinical Skills 1
Anatomy 1
Endocrinology 1
Allergy Drugs 1
Asthma Drugs 1
Sexual and Reproductive Health Drugs 1

SHOW ALL

REPORT TYPE

All Reports

Company Reports

Market Reports

Google Reviews

4.8



279 reviews

894 Results (Page 2 of 45)
- Relevance
  Sort by

Clinical Stage Partnering Terms and Agreements in Pharma and Biotech 2020-2025

 Report
August 2025
1500 Pages +
Global

From

€4414EUR$4,995USD£3,829GBP

Ranibizumab Drugs & Biosimilars Market - Global Forecast 2025-2030

 Report
August 2025
195 Pages
Global

From

€3133EUR$3,545USD£2,718GBP

€3481EUR$3,939USD£3,020GBP

Aß Monoclonal Antibody Drug Market - Global Forecast 2025-2030

 Report
August 2025
197 Pages
Global

From

€3133EUR$3,545USD£2,718GBP

€3481EUR$3,939USD£3,020GBP

Idiopathic Pulmonary Fibrosis - Global Strategic Business Report

 Report
September 2025
181 Pages
Global

From

€5170EUR$5,850USD£4,485GBP

Hemophilia Treatment - Global Strategic Business Report

 Report
September 2025
476 Pages
Global

From

€5170EUR$5,850USD£4,485GBP

NEED HELP FINDING THE RIGHT PRODUCT? Eman will help you find what you are looking for.

Call: 1-800-526-8630 ASK A QUESTION REQUEST A CALL BACK

Rare Hemophilia Factors - Global Strategic Business Report

 Report
September 2025
132 Pages
Global

From

€5170EUR$5,850USD£4,485GBP

Alzheimer's Disease Diagnostics and Therapeutics - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2021 - 2029

 Report
February 2024
117 Pages
Global

From

€4197EUR$4,750USD£3,642GBP

Alzheimer's Disease Diagnostics & Therapeutics Market - Global Forecast 2025-2030

 Report
August 2025
187 Pages
Global

From

€3133EUR$3,545USD£2,718GBP

€3481EUR$3,939USD£3,020GBP

Anxiety Disorders And Depression Treatment Market Analysis & Forecast 2024-2034: Market By Drug Class; By Indication; By Distribution Channel; and By Region

 Report
October 2023
145 Pages
Global

From

€2784EUR$3,150USD£2,415GBP

Anti-vascular Endothelial Growth Factor Therapeutics Market Size, Share & Trends Analysis Report By Product (Eylea, Lucentis, Beovu), By Disease (Macular Edema, Diabetic Retinopathy, Retinal Vein Occlusion), By Region, And Segment Forecasts, 2025 - 2030

 Report
November 2024
120 Pages
Global

From

€5258EUR$5,950USD£4,562GBP

Monoclonal Antibody Collaboration and Licensing Deals 2019-2025

 Report
May 2025
350 Pages
Global

From

€3530EUR$3,995USD£3,063GBP

Psoriatic Arthritis Treatment - Global Strategic Business Report

 Report
September 2025
452 Pages
Global

From

€5170EUR$5,850USD£4,485GBP

Preclinical Stage Partnering Terms and Agreements in Pharma and Biotech 2020-2025

 Report
August 2025
1500 Pages +
Global

From

€4414EUR$4,995USD£3,829GBP

Co-development Deals in Pharmaceuticals and Biotechnology 2016 to 2025

 Report
September 2025
450 Pages
Global

From

€3530EUR$3,995USD£3,063GBP

Psoriasis Market Report 2025

 Report
April 2025
175 Pages
Global

From

€3968EUR$4,490USD£3,442GBP

Fc Protein and Glyco-engineered Antibodies Market: Focus on Type of Fc Engineering and Therapeutics (3rd edition), 2021-2030

 Report
July 2021
290 Pages
Global

From

€4241EUR$4,799USD£3,679GBP

Manufacturing and Supply Deals in Pharmaceuticals and Biotechnology 2020-2025

 Report
September 2025
550 Pages
Global

From

€3530EUR$3,995USD£3,063GBP

Option and Evaluation Deals in Pharmaceuticals and Biotechnology 2019-2025

 Report
September 2025
750 Pages
Global

From

€3530EUR$3,995USD£3,063GBP

Lupus Therapeutics - Global Strategic Business Report

 Report
September 2025
182 Pages
Global

From

€5170EUR$5,850USD£4,485GBP

Targeted Protein Degradation Market: Focus on Technology Platforms and Therapeutics: Distribution by Type of Protein degrader, Therapeutic Areas, Route of administration, Key Contributing Technologies and Key Geographies, 2021-2030

 Report
March 2021
330 Pages
Global

From

€4241EUR$4,799USD£3,679GBP

894 Results (Page 2 of 45)
- 1
- 2
- 3
- 4

ASK A QUESTION

An error occurred while sending the message. Should this issue persist, email us at help@researchandmarkets.net

*Required Information

Name*

Email Address* Please provide your business or academic email address.

Country*

Phone Number*

Your Question*

I have read Research and Markets' Privacy Policy and consent to the processing of my personal data.

We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day.